| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,051 | 18,143 | 20,609 | 21,609 | | Cost of Revenue | 12,944 | 11,284 | 12,083 | 13,563 | | | Gross Profit | 7,107 | 6,859 | 8,526 | 8,046 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,182 | 2,476 | 2,693 | 2,491 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 972 | 884 | 887 | 973 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,953 | 3,499 | 4,946 | 4,582 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 6 | 13 | 30 | | Earnings Before Interest And Taxes | 3,958 | 3,505 | 4,959 | 4,612 | | Interest Expense | 128 |
-
|
-
|
-
| | Income Before Tax | 3,830 | 3,505 | 4,959 | 4,612 | | Income Tax Expense | 1,255 | 1,285 | 1,498 | 1,615 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,575 | 2,220 | 3,461 | 2,997 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (662) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,575 | 2,220 | 3,461 | 2,335 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,575 | $2,220 | $3,461 | $2,335 |
|
0.31% Nasdaq 0.00%
Income Statement
